Published in Diabetes on July 01, 2000
Increased physical activity decreases hepatic free fatty acid uptake: a study in human monozygotic twins. J Physiol (2006) 0.83
Exercise restores skeletal muscle glucose delivery but not insulin-mediated glucose transport and phosphorylation in obese subjects. J Clin Endocrinol Metab (2006) 0.80
Hormonal response to lipid and carbohydrate meals during the acute postprandial period. J Int Soc Sports Nutr (2011) 0.77
Muscle fractal vascular branching pattern and microvascular perfusion heterogeneity in endurance-trained and untrained men. J Physiol (2003) 0.77
Human brown adipose tissue [(15)O]O2 PET imaging in the presence and absence of cold stimulus. Eur J Nucl Med Mol Imaging (2016) 0.76
Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care (2000) 4.14
Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med (1988) 3.41
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia (2009) 3.33
Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest (1987) 2.96
Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia (2006) 2.88
Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical application. Diabetes Technol Ther (2008) 2.70
Influence of the blood glucose concentration on FDG uptake in cancer--a PET study. J Nucl Med (1993) 2.66
PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology (2007) 2.63
Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med (1992) 2.40
Transcriptional regulation of the lactase-phlorizin hydrolase gene by polymorphisms associated with adult-type hypolactasia. Gut (2003) 2.33
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes. Diabetes Obes Metab (2010) 2.30
Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia (2004) 2.12
Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease. Neurology (2006) 1.85
Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med (2006) 1.84
Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest (1987) 1.83
Natural course of insulin resistance in type I diabetes. N Engl J Med (1986) 1.82
Hyperuricemia and insulin resistance. J Clin Endocrinol Metab (1994) 1.82
Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and [(18)F]fluoroerythronitroimidazole PET. J Nucl Med (2001) 1.81
Insulins today and beyond. Lancet (2001) 1.71
The "dawn phenomenon"--a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. N Engl J Med (1984) 1.61
Recurrent low back pain and early disc degeneration in the young. Spine (Phila Pa 1976) (1999) 1.59
Hyperglycemia decreases glucose uptake in type I diabetes. Diabetes (1987) 1.58
Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus. Diabetologia (1999) 1.58
Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes (2001) 1.57
Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. Diabetologia (2009) 1.53
Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia (1997) 1.49
Liver transplantation in the Nordic countries, 1982-1998: changes of indications and improving results. Scand J Gastroenterol (1999) 1.45
Cardiovascular response to exercise in diabetic patients: influence of autonomic neuropathy of different severity. Diabetologia (1995) 1.42
Insulin increases the release of endothelin in endothelial cell cultures in vitro but not in vivo. Metabolism (1994) 1.42
Hyperreactivity to nitrovasodilators in forearm vasculature is related to autonomic dysfunction in insulin-dependent diabetes mellitus. Circulation (1997) 1.41
A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. Diabetes (1984) 1.39
Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance. J Clin Endocrinol Metab (1999) 1.37
Outbreak of parasitic peritonitis in reindeer in Finland. Vet Rec (2007) 1.37
Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet (1995) 1.37
Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes (1999) 1.37
Physical training and insulin sensitivity. Diabetes Metab Rev (1986) 1.37
Bayesian image reconstruction for emission tomography based on median root prior. Eur J Nucl Med (1997) 1.34
Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia (2007) 1.34
Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome. Diabetologia (2007) 1.31
Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest (1992) 1.30
Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes (1995) 1.30
Diabetes and breast cancer risk: a meta-analysis. Br J Cancer (2012) 1.30
Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR). Hypertension (1997) 1.30
Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology (Berl) (1994) 1.29
Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes (1994) 1.29
Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation (1996) 1.27
Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation (1996) 1.26
Enhanced oxygen extraction and reduced flow heterogeneity in exercising muscle in endurance-trained men. Am J Physiol Endocrinol Metab (2001) 1.26
Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle. J Clin Invest (1987) 1.25
Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia (1995) 1.25
Effects of whole-body vibration exercise on the endocrine system of healthy men. J Endocrinol Invest (2004) 1.23
Kinetic modeling of [(18)F]FDG in skeletal muscle by PET: a four-compartment five-rate-constant model. Am J Physiol Endocrinol Metab (2001) 1.22
Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab (1988) 1.22
Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia. Schizophr Res (1999) 1.20
Quantitative blood flow measurement of skeletal muscle using oxygen-15-water and PET. J Nucl Med (1997) 1.19
A novel phylogeny for the genus Echinococcus, based on nuclear data, challenges relationships based on mitochondrial evidence. Parasitology (2009) 1.19
A phylogeny of members of the family Taeniidae based on the mitochondrial cox1 and nad1 gene data. Parasitology (2008) 1.18
Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol (1997) 1.17
Muscle blood flow and flow heterogeneity during exercise studied with positron emission tomography in humans. Eur J Appl Physiol (2000) 1.16
Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia (1996) 1.16
The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity. Diabetologia (1991) 1.16
Intense physical training decreases circulating antioxidants and endothelium-dependent vasodilatation in vivo. Atherosclerosis (1999) 1.16
Hypoglycemia in IDDM. Diabetes (1989) 1.15
Glucose counterregulation and waning of insulin in the Somogyi phenomenon (posthypoglycemic hyperglycemia). N Engl J Med (1984) 1.14
Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone. J Nucl Med (2000) 1.14
Coronary flow reserve is reduced in young men with IDDM. Diabetes (1998) 1.13
Sex and insulin sensitivity. Metabolism (1984) 1.13
Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes (1998) 1.11
Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride. J Cereb Blood Flow Metab (1993) 1.11
Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4 h in normal subjects. Diabetes (1996) 1.11
Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes. Arteriosclerosis (1988) 1.11
Back extensor and psoas muscle cross-sectional area, prior physical training, and trunk muscle strength--a longitudinal study in adolescent girls. Eur J Appl Physiol Occup Physiol (1998) 1.11
Demonstration of a dawn phenomenon in normal human volunteers. Diabetes (1984) 1.10
Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women. Circulation (2000) 1.10
FDG-PET in early infancy: simplified quantification methods to measure cerebral glucose utilization. J Nucl Med (1995) 1.09
In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. Diabetes Care (1999) 1.09
Uptake of 11C-methionine in breast cancer studied by PET. An association with the size of S-phase fraction. Br J Cancer (1991) 1.08
Lumbar mobility and low back pain during adolescence. A longitudinal three-year follow-up study in athletes and controls. Am J Sports Med (1997) 1.07
[Offer hepatitis B vaccination to the addicts. Transmission of hepatitis B among intravenous drug abusers]. Lakartidningen (1993) 1.07
Role of blood flow in regulating insulin-stimulated glucose uptake in humans. Studies using bradykinin, [15O]water, and [18F]fluoro-deoxy-glucose and positron emission tomography. J Clin Invest (1996) 1.07
Free fatty acid kinetics and oxidation in congestive heart failure. Am J Cardiol (1998) 1.07
Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance. Diabetologia (2004) 1.06
Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes. J Clin Endocrinol Metab (1984) 1.05
Level of skeletal muscle glucose transporter protein correlates with insulin-stimulated whole body glucose disposal in man. Diabetologia (1991) 1.05
Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women. Thromb Haemost (2001) 1.05
Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. N Engl J Med (1985) 1.03
Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. N Engl J Med (1984) 1.02